To access this element change to forms mode OFF
Grant Award View - GA201461
Improving outcomes for lung cancer patients: Discovering targetable...
GA ID:
GA201461
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
10-Sep-2021
Publish Date:
10-Nov-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$5,500,000.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Synergy Grants
Grant Activity:
Improving outcomes for lung cancer patients: Discovering targetable vulnerabilities in lung cancer
Purpose:
Lung cancer is the leading cause of cancer-related mortality. One major hurdle faced in the clinic is that many patients fail to respond to currently available anti-cancer drugs. We will leverage the expertise of a diverse team of scientists and clinicians to tease apart the processes that can cause lung cancer to become refractory to current treatments. The discoveries made in this proposal will catalyse translational programs that will lead to improved ways to detect and treat lung cancer.
GO ID:
GO Title:
Synergy Grants 2021
Internal Reference ID:
2021/GNT2010275
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC, QLD
Postcode:
Multiple
Country:
AUSTRALIA